Atlas Trials

Characterization of the Kinetics of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (T2DM)

Clinical trial NCT01165268 · COMPLETED

Trial details

NCT number
NCT01165268
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2010-08-01
Primary completion
2010-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.